Maple Capital Management’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Sell |
3,850
-2
| -0.1% | -$156 | 0.02% | 97 |
|
|
2025
Q1 | $279K | Buy |
3,852
+277
| +8% | +$20.1K | 0.02% | 98 |
|
|
2024
Q4 | $265K | Sell |
3,575
-58
| -2% | -$4.29K | 0.02% | 98 |
|
|
2024
Q3 | $240K | Buy |
3,633
+58
| +2% | +$3.83K | 0.02% | 102 |
|
|
2024
Q2 | $330K | Hold |
3,575
| – | – | 0.03% | 96 |
|
|
2024
Q1 | $342K | Buy |
3,575
+428
| +14% | +$40.9K | 0.03% | 86 |
|
|
2023
Q4 | $240K | Buy |
3,147
+11
| +0.4% | +$839 | 0.02% | 92 |
|
|
2023
Q3 | $217K | Buy |
3,136
+11
| +0.4% | +$762 | 0.02% | 93 |
|
|
2023
Q2 | $295K | Hold |
3,125
| – | – | 0.03% | 83 |
|
|
2023
Q1 | $259K | Buy |
3,125
+332
| +12% | +$27.5K | 0.03% | 83 |
|
|
2022
Q4 | $208K | Buy |
2,793
+45
| +2% | +$3.36K | 0.03% | 91 |
|
|
2022
Q3 | $202K | Buy |
2,748
+18
| +0.7% | +$1.32K | 0.03% | 91 |
|
|
2022
Q2 | $260K | Hold |
2,730
| – | – | 0.03% | 81 |
|
|
2022
Q1 | $321K | Buy |
2,730
+923
| +51% | +$109K | 0.04% | 83 |
|
|
2021
Q4 | $234K | Buy |
+1,807
| New | +$234K | 0.03% | 100 |
|